- Member Center
-
PCNA Membership
Enhance your career and improve patient outcomes
Mentoring Program
Learn about mentoring from a real PCNA mentee
- Join PCNA
- Member Benefits
- Membership Options
- Chapters
- Student Membership
-
- Meetings
-
PCNA Chapter Programs
Find local events in your area
PCNA 19th Annual Symposium
Las Vegas - May 2-4, 2013
- Annual Symposium
- Fall Programs
- Chapter Programs
- Calendar of Events
-
- Online Education
-
PCNA Fall Programs
Register for a free CE program in your city
Intuitive Eating CE Program
Earn 1 CE with this new on-demand CE course
- Live Webinars
- On Demand CE Courses
- Streamed Events
-
- Clinical Tools
-
Antiplatelet Therapy
Order free patient education handouts
PCNA Chapter Programs
Find local events in your area
- Tools for Healthcare Providers
- Education for your Patients
-
- Advocacy
-
TellAFriend
A PCNA campaign about Women & Heart Disease
- Action Center
- Advocacy News
-
- Global Prevention
- Home
Press Archive - Preventive Cardiovascular Nurses Association
MEDIA ALERT: PCNA 19th Annual Symposium to Feature CVD Prevention Science, Education
MEDIA ALERT: PCNA 19th Annual Symposium to Feature CVD Prevention Science, Education LAS VEGAS, May 2, 2013 Preventive Cardiovascular Nurses Association (PCNA) will be hosting their 19th Annual Symposium from May 2-4, 2013 at the Paris Las Vegas Hotel in Las Vegas, Nevada. The scientific symposium will feature keynote speakers and concurrent sessions from world-renowned faculty in the field of…
Published in
Scientific Conferences
Sunday, 10 March 2013 14:51
PCNA Response: TERISA Trial, ACC.13 Scientific Sessions
SAN FRANCISCO, March 10, 2013 The TERISA Trial, presented on Sunday at the American College of Cardiology Scientific Sessions 2013, revealed data that shows the effectiveness of renolazine in reducing angina frequency and SL NTG in patients with type 2 diabetes, CAD and chronic angina. “This promising data shows beneficial outcomes in type 2 diabetic patients treated with renolazine,” states…
Published in
Scientific Conferences
Sunday, 10 March 2013 14:49
PCNA Response: TACT Trial, ACC.13 Scientific Sessions
SAN FRANCISCO, March 10, 2013 The Trial to Assess Chelation Therapy (TACT), presented on Sunday at the American College of Cardiology 2013 Scientific Sessions, revealed results of partnering high-dose vitamins with chelation therapy for a primary endpoint of impacting total mortality, recurrent myocardial infarction, stroke, coronary revascularization, and hospitalization for angina. “The NIH funded trial did show some benefit of…
Published in
Scientific Conferences
Sunday, 10 March 2013 14:33
REMINDER Trial finds early administration of eplerenone in patients with acute STEMI improves cardiovascular outcomes
SAN FRANCISCO, March 10, 2013 The REMINDER trial, presented on Sunday at the American College of Cardiology 2013 Scientific Sessions, revealed that the addition of eplerenone to standard therapy within 24 hours of symptom onset improves outcomes of patients with acute STEMI without evidence of heart failure. “The benefit of eplerenone in the acute phase is very significant,” states Barbara…
Published in
Scientific Conferences
HPS2-THRIVE study proves no benefit from adding extended release niacin in patients with pre-existing cardiovascular disease
SAN FRANCISCO, March 9, 2013 A new study, HPS2-THRIVE, presented at the ACC 2013 Scientific Session in San Francisco reveals that the addition of extended release (ER) niacin to patients on statin therapy with well-controlled LDL shows no significant reduction in major vascular events. The trial, which studied over 25,000 patients over four years, revealed a 4% non-significant reduction in…
Published in
Scientific Conferences
